Cargando…
Regulatory Mechanisms and Clinical Applications of the Long Non-coding RNA PVT1 in Cancer Treatment
Cancer is the second leading cause of death worldwide, and no obvious decline in incidence and mortality has occurred in recent years. It is imperative to further investigate the mechanisms underlying tumor progression. Long non-coding RNAs have received considerable attention in recent years becaus...
Autores principales: | Li, Meng-Yuan, Tang, Xiao-Huan, Fu, Yan, Wang, Tie-Jun, Zhu, Jia-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712078/ https://www.ncbi.nlm.nih.gov/pubmed/31497532 http://dx.doi.org/10.3389/fonc.2019.00787 |
Ejemplares similares
-
PVT1 Long Non-coding RNA in Gastrointestinal Cancer
por: Martínez-Barriocanal, Águeda, et al.
Publicado: (2020) -
Long non-coding RNA PVT1: A promising chemotherapy and radiotherapy sensitizer
por: Yao, Weiping, et al.
Publicado: (2022) -
Long Non-coding RNA PVT1 as a Prognostic and Therapeutic Target in Pediatric Cancer
por: Boloix, Ariadna, et al.
Publicado: (2019) -
Long non-coding RNA PVT1 (PVT1) affects the expression of CCND1 and promotes doxorubicin resistance in osteosarcoma cells
por: Li, Zi, et al.
Publicado: (2023) -
Noncoding RNA PVT1 in osteosarcoma: The roles of lncRNA PVT1 and circPVT1
por: Wu, Tingrui, et al.
Publicado: (2022)